News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gerresheimer Strengthens Business in Russia


4/9/2010 8:03:15 AM

Gerresheimer AG has set up a sales office in Moscow. The new representation centre will intensify the Group’s business in pharmaceutical primary packaging and drug-delivery systems. “This is a strategically important step to further develop the fast-growing pharma & healthcare markets of Russia and neighboring regions,“ says Gerresheimer CEO Dr. Axel Herberg.

The Duesseldorf Group, which has been active in Russia for many years, has numerous customers there. For example the Group supplies the Moscow company Petrovax Pharm with large quantities of pre-sterilized RTF® (Ready To Fill) syringes for vaccines. The business in high-quality pharma vials and ampoules is also well established. Regional representation will contribute to intensification not only of sales operations but also customer advice and technical service on the spot. In general, the Russian pharma industry has a strong interest in developing its quality and technologies together with competent partners.

This fast-growing pharma & healthcare market is seen as extremely dynamic and offers Gerresheimer good growth opportunities.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of highquality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges from pharmaceutical vials to complex drug delivery systems, such as syringe systems, insulin pens and inhalers, for safe dosage and application. Together with our partners we develop solutions which set standards and have role-model status throughout their respective business sectors. Our Group of companies achieves in Europe, North and South America and Asia sales of about €1 billion and employs around 9,400 people. Through top-class technologies, convincing innovations and targeted investments we are systematically expanding our strong market position.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES